The clinical significance of IGF2BP3 expression was assessed using immunohistochemistry (IHC) in 183 paraffin-embedded NPC specimens (Fig. 1C and Supplementary Table S1). This evidence concerns the gene IGF2BP3 and nasopharyngeal carcinoma.